Search Results 1041-1050 of 17076 for monoclonal antibody

1. A Study to Evaluate Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant - Mayo Clinic

   History of severe allergic or anaphylactic reactions to humanized or murine monoclonal antibodies;; Known active bacterial, viral (e.g., HIV, hepatitis B ...

2. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

   Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...

3. A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer - Mayo Clinic

   ... antibodies and the factors that may determine disease progression and treatment response. ... Plan to initiate treatment with either bi-specific antibody or CAR-T ...

4. A Study Evaluating the Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

   Anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative; and; An anthracycline containing chemotherapy regimen. Intent to ...

5. A Study of to Evaluate Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer - Mayo Clinic

   ... monoclonal antibody, or other agents used in the study. Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection ...

6. Health Topics - Mayo Clinic News Network

   DEAR MAYO CLINIC: I have high blood pressure and was just diagnosed as having chronic kidney disease. I am disheartened by this news, but I[...] ...

7. Autoimmune epilepsy - Diagnosis and treatment - Mayo Clinic

   Lab tests. Lab tests check for antibodies in the immune system that are attacking brain cells and causing seizures.

8. Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol - Mayo Clinic

   ... antibodies in your blood samples. The biomarker and antibody results along with your personal medical profile will be evaluated to determine your risk for ...

9. A Study to Evaluate RVT-1401 for the Treatment of Patients with Active, Moderate-to-severe Graves' Ophthalmopathy - Mayo Clinic

   Use of rituximab, tocilizumab, or any monoclonal antibody/Fc-fusion biologic for immunomodulation within the past 9 months prior to Baseline. Use of ...

10. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

    Bezlotoxumab (CDI monoclonal antibodies) if received within the last year. Disease symptoms (e.g., diarrhea) caused by a confirmed intestinal pathogen other ...